FCGR2A and cancer: In the investigation at hand, we synthesized and characterized <sup>89</sup>Zr-labeled probes based on wild-type and aglycosylated variants of the CA19-9-targeting antibody 5B1 and evaluated their in vivo behavior in several murine models of cancer, including immunocompetent and FcγR-humanized mice.